A genome-wide association study of recipient genotype and medium-term kidney allograft function

Clinical Transplantation

Volumn 27, Issue 3, 2013, Pages 379-387

  O'Brien, Robert P ^a   Phelan, Paul J ^b   Conroy, Judith ^c   O'Kelly, Patrick ^b   Green, Andrew ^c   Keogan, Mary ^b   O'Neill, Derek ^b   Jennings, Susan ^b   Traynor, Carol ^b   Casey, Jillian ^c   Mccormack, Mark ^a   Conroy, Ronan ^a   Chubb, Anthony ^c   Ennis, Sean ^c   Shields, Denis C ^c   Cavalleri, Gianpiero L ^a   Conlon, Peter J ^b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Allograft outcome; Genome wide association studies; Renal transplantation; SNP; Survival

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; SPACER DNA; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ADULT; ARTICLE; CHROMOSOME 14; CHROMOSOME 18; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT OUTCOME; ALLOGRAFT; BLOOD; COHORT ANALYSIS; FOLLOW UP; GENETICS; GRAFT REJECTION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MORTALITY; PROGNOSIS; SURVIVAL RATE;

ADULT; ALLOGRAFTS; COHORT STUDIES; CREATININE; FEMALE; FOLLOW-UP STUDIES; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; SURVIVAL RATE;

EID: 84878660707     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12093     Document Type: Article

References (36)

1. Loubeau PR, Loubeau JM, Jantzen R. The economics of kidney transplantation versus hemodialysis. Prog Transplant 2001: 11: 291.
2. OPTN Annual Report 2011(http://optn.transplant.hrsa.gov/data/annualReport.asp)
3. Kottgen A, Kao WH, Hwang SJ et al. Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet 2008: 9: 49.
4. Kottgen A, Pattaro C, Böger CA et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010: 42: 376.
5. Chambers JC, Zhang W, Lord GM et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 2010: 42: 373.
6. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007: 81: 559.
7. Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2008.
8. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006: 38: 904.
9. Ge D, Zhang D, Need AC, Martin O, Fellay J, Telenti A, Goldstein DB. WGAViewer: software for Genomic Annotation of Whole Genome Association Studies. Genome Res. 2008:18:640 [Dongliang Ge & David B. Goldstein. http://compute1.lsrc.duke.edu/softwares/WGAViewer/]
10. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp.
11. Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions, 3rd edn. New York: Wiley, 2003.
12. 1000 Genomes [http://www.1000genomes.org/].
13. International HapMap 3 Consortium, Altshuler DM, Gibbs RA et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010: 467: 52.
14. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, De Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008: 24: 2938.
15. Gauderman WJ. Candidate gene association analysis for a quantitative trait, using parent-offspring trios. Genet Epidemiol 2003: 25: 327.
16. Kuo HT, Ye X, Sampaio MS, Reddy P, Bunnapradist S. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Transplantation 2010: 90: 1091.
17. Sagedal S, Hartmann A, Rollag H. The impact of early cytomegalovirus infection and disease in renal transplant recipients. Clin Microbiol Infect 2005: 11: 518.
18. Alberu J, Morales-Buenrostro LE, Correa-Rotter R et al. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy. Rev Invest Clin 2008: 60: 365.
19. Petersen P, Schneeberger H, Schleibner S, Illner WD, Hofmann GO, Land W. Positive donor and negative recipient cytomegalovirus status is a detrimental factor for long-term renal allograft survival. Transpl Int 1994: 7(Suppl 1):S336.
20. Noppakun K, Cosio FG, Dean PG, Taler SJ, Wauters R, Grande JP. Living donor age and kidney transplant outcomes. Am J Transplant 2011: 11: 1279.
21. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplant 1997: 11(5 Pt 1): 366.
22. Salvadori M, Rosati A, Bock A et al. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Transplantation 2006: 81: 202.
23. Kraft P. Curses-winner's and otherwise-in genetic epidemiology. Epidemiology 2008: 19:649; discussion 648.
24. Meier-Kriesche HU, Ojo AO, Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000: 70: 1098.
25. Cole EH, Johnston O, Rose CL, Gill JS. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol 2008: 3: 814.
26. Opelz G, Mickey MR, Terasaki PI. HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation 1977: 23: 490.
27. Kruger B, Schroppel B. Genetic variations and transplant outcomes. Nephron Clin Pract 2011: 118: c49.
28. Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study. Transplantation 2007: 83: 1055.
29. Winkelmayer WC, Kramar R, Sunder-Plassmann G, Fodinger M. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int 2005: 68: 2857.
30. Cox ED, Hoffmann SC, DiMercurio BS et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001: 72: 720.
31. Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol 2006: 16: 194.
32. Park JY, Park MH, Park H, Ha J, Kim SJ, Ahn C. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens 2004: 64: 660.
33. Goldfarb-Rumyantzev AS, Naiman N. Genetic prediction of renal transplant outcome. Curr Opin Nephrol Hypertens 2008: 17: 573.
34. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009: 4: 481.
35. Lefranc MP. Organization of the human T-cell receptor genes. Eur Cytokine Netw 1990: 1: 121.
36. Hallmayer J, Faraco J, Lin L et al. Narcolepsy is strongly associated with the TCR alpha locus. Nat Genet 2009: 41: 708.